Innovate Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -3.16%
(FY 2023)
- Ebitda -3.16%
(FY 2023)
- Net Worth -202.21%
(FY 2023)
- Total Assets 152.14%
(FY 2023)
About Innovate Lifesciences
The Corporate was formerly known as Diabeato Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narendrasinh Devda, Jayantilal Patel, Govindsingh Chavda, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300GJ2020PTC112885
- Company No.
112885
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Innovate Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Jain  | Director | 03-Mar-2020 | Current |
| Narendrasinh Devda | Director | 21-Feb-2020 | Current |
| Jayantilal Patel | Director | 06-Aug-2021 | Current |
Govindsingh Chavda  | Director | 21-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Innovate Lifesciences.
Innovate Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 3.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 202.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovate Lifesciences?
Unlock access to Innovate Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Infinion Biopharma LimitedActive 6 years 11 monthsNarendrasinh Devda, Govindsingh Chavda and 1 more are mutual person
- Axon Hospitality Private LimitedActive 5 years 5 months
Narendrasinh Devda and Govindsingh Chavda are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovate Lifesciences?
Unlock and access historical data on people associated with Innovate Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovate Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovate Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
